The Blue Box Biomedical Solutions

PROFESSIONAL

01 EL PROBLEMA

1/8

mujeres

tendrá cáncer de mama al menos una vez a lo largo de su vida

1/8

mujeres

tendrá cáncer de mama al menos una vez a lo largo de su vida

1/8

mujeres

tendrá cáncer de mama al menos una vez a lo largo de su vida

01 EL PROBLEMA

NECESIDAD DE UNA PRUEBA INDOLORA Y NO IRRADIANTE
PARA DETECTAR EL CÁNCER DE MAMA

SENSIBILIDAD

TASA DE CLASIFICACIÓN

ESPECIFICIDAD

MAMMOGRAPHY

IN WOMEN AGED <50

73%

58%

88%

THE BLUE BOX

IN WOMEN AGED <50

85%

79%

71%

OUR MISSION

Women aged 20-45 cannot get screened for BC because existing solutions are unreliable. However, they want to. At The Blue Box, we have built a urine-based pain-free, low-cost, sensitive, radiation-free device to make breast cancer detection accessible.

In 2024, we’ll launch into the market, bringing The Blue Box to private gynaecology clinics with a Diagnostics-as-a-Service subscription model, and a pay-per-test revenue stream that we’ll share with doctors.